Behandlung der psoriasis mit biologics

Rebekka Salgo; Diamant Thaçi

Behandlung der psoriasis mit biologics

Translated title of the contribution: Treatment of psoriasis with biologics

Rebekka Salgo, Diamant Thaçi^*

^*Corresponding author for this work

Institute of Inflammation Medicine

Johann Wolfgang Goethe-University

Abstract

Psoriasis is a chronic-inflammatory skin disease. In case of moderate and severe psoriasis (approximately 20-30 % of all patients), systemic treatment is necessary. Recent findings regarding the pathomechanism of psoriasis led to the development of targeting molecules, so-called biologics. These biotechnical products are able to selectively block mediators that are relevant for inflammation or to block the interaction between cells, imitating or inhibiting natural proteins.

Translated title of the contribution	Treatment of psoriasis with biologics
Original language	German
Journal	Haut
Volume	18
Issue number	1
Pages (from-to)	6-9
Number of pages	4
ISSN	0938-2216
Publication status	Published - 02.2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this

@article{4ee4bc2528bf4f8ca5fd4bcabb171ccb,

title = "Behandlung der psoriasis mit biologics",

abstract = "Psoriasis is a chronic-inflammatory skin disease. In case of moderate and severe psoriasis (approximately 20-30 \% of all patients), systemic treatment is necessary. Recent findings regarding the pathomechanism of psoriasis led to the development of targeting molecules, so-called biologics. These biotechnical products are able to selectively block mediators that are relevant for inflammation or to block the interaction between cells, imitating or inhibiting natural proteins.",

author = "Rebekka Salgo and Diamant Tha{\c c}i",

year = "2007",

month = feb,

language = "Deutsch",

volume = "18",

pages = "6--9",

journal = "Haut",

issn = "0938-2216",

publisher = "WPV Wirtschafts- und Praxisverlag GmbH",

number = "1",

}

TY - JOUR

T1 - Behandlung der psoriasis mit biologics

AU - Salgo, Rebekka

AU - Thaçi, Diamant

PY - 2007/2

Y1 - 2007/2

N2 - Psoriasis is a chronic-inflammatory skin disease. In case of moderate and severe psoriasis (approximately 20-30 % of all patients), systemic treatment is necessary. Recent findings regarding the pathomechanism of psoriasis led to the development of targeting molecules, so-called biologics. These biotechnical products are able to selectively block mediators that are relevant for inflammation or to block the interaction between cells, imitating or inhibiting natural proteins.

AB - Psoriasis is a chronic-inflammatory skin disease. In case of moderate and severe psoriasis (approximately 20-30 % of all patients), systemic treatment is necessary. Recent findings regarding the pathomechanism of psoriasis led to the development of targeting molecules, so-called biologics. These biotechnical products are able to selectively block mediators that are relevant for inflammation or to block the interaction between cells, imitating or inhibiting natural proteins.

UR - https://www.scopus.com/pages/publications/34347404054

M3 - Übersichtsarbeiten

AN - SCOPUS:34347404054

SN - 0938-2216

VL - 18

SP - 6

EP - 9

JO - Haut

JF - Haut

IS - 1

ER -

Behandlung der psoriasis mit biologics

Abstract

UN SDGs

Research Areas and Centers

Other files and links

Fingerprint

Cite this